Concepedia

Ho Man Chan

HM

Statistics

Publications

19

Citations

3.5K

H-Index

16

Active since

1998

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Novartis (United States)

AstraZeneca (United States)

University of Glasgow

Ho Man Chan is an author at Harvard University specializing in life sciences, molecular biology, and molecular oncology.

ORCID

Publications per year

1998–2025

19

Publications

19

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations

, , +16

Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

Steven R. Grossman, Maria E. Deato, Chrystelle Brignone et al. · Science · 2003 · 457 citations

, , +13

A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation

Brittany C. Michel, Seth H. Cassel, Nazar Mashtalir et al. · Nature Cell Biology · 2018 · 437 citations

, , +11

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

Jacob D. Jaffe, Yan Wang, Ho Man Chan et al. · Nature Genetics · 2013 · 284 citations · Full text

, , +11

Acetylation control of the retinoblastoma tumour-suppressor protein

Ho Man Chan, Marija Krstic–Demonacos, Linda Smith et al. · Nature Cell Biology · 2001 · 278 citations

, , +13

1–5 of 19